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Abstract
Background: The human homologue of the Drosophila Discs-large tumor suppressor protein, hDlg, is a multi-
domain cytoplasmic protein that localizes to the membrane at intercellular junction sites. At both synaptic
junctions and epithelia cell-cell junctions, hDlg is known to recruit several signaling proteins into macromolecular
complexes. hDlg is also found at the midbody, a small microtubule-rich structure bridging the two daughter cells
during cytokinesis, but its function at this site is not clear.
Results: Here we describe the interaction of hDlg with the activated form of MEK2 of the canonical RAF/MEK/ERK
pathway, a protein that is found at the midbody during cytokinesis. We show that both proteins localize to a sub-
structure of the midbody, the midbody ring, and that the interaction between the PDZ domains of hDlg and the
C-terminal portion of MEK2 is dependent on the phosphorylation of MEK2. Finally, we found that E-cadherin also
localizes to the midbody and that its expression is required for the isoform-specific recruitment of hDlg, but not
activated MEK2, to that structure.
Conclusion: Our results suggest that like at other cell-cell junction sites, hDlg is part of a macromolecular complex
of structural and signaling proteins at the midbody.
Background
hDlg, the human homologue of the Drosophila Dlg
tumor suppressor, is an alternatively spliced protein that
belongs to the membrane-associated guanylate kinase
(MAGUK) protein family. MAGUKs are characterized
by several protein interaction domains: three PDZ
domains, an SH3 domain, a guanylate kinase-like
domain (GK), and a L27 self-association domain [1,2].
Most PDZ domains bind to the C-terminal portion of
proteins often characterized by one of three consensus
sequence classes: -X-(S/T)-X-F (Class I), -X-FX-F
(Class II), -X-(D/E/K//R)-X-F (Class III) (where F
represents an aliphatic residue; [3]), with all four term-
inal residues additively contributing to interaction speci-
ficity [4]. The three PDZ repeats of hDlg use this
mechanism to bind to several proteins involved in cellu-
lar growth control including the adenomatous polyposis
coli (APC) tumor suppressor [5,6], the human
papillomavirus E6 protein [7], the adenovirus E4 protein
[8], the mitotic Ser/Thr kinase PBK/TOPK [9], and p38g
MAP kinase [10]. The GK domain of hDlg also recruits
several proteins into macromolecular complexes: GKAP/
SAPAP [11,12], the PKA-targeting protein AKAP79/150
[13], and the microtubule-associated protein MAP1A
[14]. The SH3 domain of hDlg forms an intramolecular
interaction with the GK domain [15]. Finally, homo-
and hetero-oligomers of MAGUK proteins form through
their L27 domains; for example, hDlg and the MAGUK
protein CASK heterodimerize through their L27
domains [16,17]. The degree of hDlg self-association
depends also on the presence or absence of the alterna-
tively spliced insertion I1A [18]. I1A and B, two proline-
rich alternatively spliced insertions upstream of the first
PDZ repeat in hDlg, recruit SH3-containing proteins
[18].
First described as a cytoplasmic protein localized at
the membrane at regions of intercellular contacts [2,19],
hDlg is responsible for the recruitment of a variety of
proteins forming a complex network at sites of epithelial
cell-cell contact and in pre-synaptic densities. For exam-
ple, hDlg has been found to be closely associated with
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More recently, I2-containing alternatively spliced var-
iants of hDlg have been reported to be found in the
nucleus of cultured human cancer cells [18,22] and of
cells from human epithelial tissues (AV, unpublished
results), and both I3- and I2- containing variants were
reported to localize to the midbody of cells in cytokin-
esis [23,24].
While the various localization sites of hDlg are known,
it is unclear what its function is at those sites. An
important step in understanding the function of hDlg as
a tumor suppressor is the identification of all of its
binding partners. Here we describe the interaction of
hDlg with the phosphorylated form of MEK2, a signal-
ing protein found, like hDlg, at the midbody of cells
undergoing cytokinesis. Importantly, our data also indi-
cate that E-cadherin concentrates in the midbody during
cytokinesis and is necessary f o rp r o p e rl o c a l i z a t i o no f
hDlg, but not phosphorylated MEK2, at the midbody.
Results
A C-terminal fragment of MEK2 interacts with hDlg
Like other members of the MAGUK family, hDlg plays
an important role in clustering signaling molecules at
sites of cell-cell contact. Most of the structural modules
found in hDlg are known to function as protein-interac-
tion domains. In an effort to identify new signaling pro-
t e i n st h a tb i n dt oh D l g ,w ep e r f o r m e dat w o - h y b r i d
screen using full-length hDlg as bait. This screen yielded
many positives. Among the clones that most strongly
activated the lacZ reporter gene was a cell cycle-regu-
lated kinase [9] and a ~900 bp sequence encoding the
C-terminal 126 residues of MEK2 (pGAD-MEK2(275-
400)). Once isolated, this MEK2 construct was retrans-
formed in S. cerevisiae HF7c with pGBT9-hDlg to con-
firm that the interaction was not due to another co-
transforming plasmid (Table 1). The MEK2 construct
was also co-transformed with a series of control plas-
mids to confirm that reporter gene activation was
indeed dependent on a specific interaction with hDlg
(Table 1); with this set of transformations we observed
the same pattern of b-galactosidase activity that was
found with a C-terminal clone of PBK, a previously
identified hDlg-interacting protein [9].
Although only MEK2 was isolated in our screen,
MEK1 and MEK2 share 80% sequence similarity [25].
Notably, their C-terminal sequences differ: only MEK2
is characterized by a conserved X-(S/T)-X-F motif
matching the consensus sequence found at the C-termi-
nus of Class I PDZ-binding proteins (Figure 1). Human,
mouse and rat MEK2 all contain this motif, while in
chicken MEK2, the threonine residue in position P-2 is
replaced by an alanine (Figure 1). MEK1 sequences from
all four species are characterized by this same Thr to
Ala substitution and by the addition of glycine or serine
at the penultimate position (Figure 1). The presence of a
PDZ-binding motif in mammalian MEK2 proteins sug-
gests that human MEK2 interacts with hDlg through
one of its three PDZ repeats.
To test our hypothesis that the C-terminus of MEK2
but not that of MEK1 interacts with the hDlg PDZ
repeats, we designed a peptide binding assay. In this
assay, peptides corresponding to the last 16 residues of
MEK2 (2CT) or MEK1 (1CT), or a randomized
sequence of the MEK2 peptide (2RD) were incubated
with a GST fusion protein containing PDZ1-PDZ2 of
hDlg (GST-PDZ1-2), a fragment of hDlg that was pre-
viously identified as a super-motif [19]. MALDI-TOF
analyses consistently showed that only the MEK2 pep-
tide bound to GST-PDZ1-2 (Figure 2A). The peptide
recovered after elution had a mass identical to the
MEK2 peptide directly spotted on the ProteinChip array
(Figure 2B, right). When the same experiment was
repeated with an unrelated GST fusion protein (contain-
ing the 14
th repeat of a-spectrin, GST-a14), the MEK2
peptide did not bind, demonstrating the specificity of
this peptide for PDZ1-2 of hDlg (Figure 2A). Binding of
the MEK2 peptide was also observed when each of the
three PDZ repeats of hDlg was expressed individually
and used in our binding assay, although our results sug-
gest that the binding is weakest with PDZ3 (Figure 2B
and data not shown). This last result corresponds well
with those of Maiga et al. (2011) who have also recently
described an interaction of hDlg with MEK2 and found,
Table 1 b-galactosidase activity of S. cerevisiae HF7c after co-transformation with indicated plasmid pair
Prey plasmid Bait plasmid Bait description b-galactosidase activity Data Source
pGAD-MEK2(275-400) pGBT9-hDlg full-length hDlg +++ This paper
pGAD-MEK2(275-400) pGBT9 vector only - This paper
pGAD-MEK2(275-400) pLAM5’ human lamin C (66-320) - This paper
pGAD-MEK2(275-400) none - This paper
pGAD-PBK(173-322) pGBT9-hDlg full-length hDlg +++ [9]
pGAD-PBK(173-322) pGBT9 vector only - [9]
pGAD-PBK(173-322) pLAM5’ human lamin C (66-320) - [9]
pGAD-PBK(173-322) none - [9]
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tide binding assay, that a C-terminal construct of MEK2
(179-400) interacts with a PDZ1-2 construct but not
with PDZ3. Overall, our peptide assay data confirmed
that MEK2, but not MEK1, has a Class I PDZ-binding
motif that interacts with the PDZ repeats of hDlg.
hDlg interacts only with activated full-length MEK2
T oc o n f i r mt h a th D l ga n dM E K 2i n t e r a c tin vivo, full-
length hMEK2 was co-expressed with a GST-hDlg
fusion protein in insect cells. Although co-infected
insect cells synthesized both proteins, our initial
attempts to show a co-purification of MEK2 and GST-
hDlg failed. The co-localization of hDlg with the phos-
phorylated form of MEK2 during cytokinesis (see below)
prompted us to test for the interaction upon stimulation
of Raf/MEK/MAP kinase pathway. Abdullah et al. (1995,
[ 2 6 ] )d e m o n s t r a t e dt h a tP M A - t r e a t m e n to fS f 9i n s e c t
cells activates this signaling pathway. We co-infected
High 5 insect cells with recombinant baculoviruses
responsible for the expression of GST-hDlg and
hMEK2. GST-hDlg was affinity purified from untreated
and PMA-treated insect cell lysates and MEK2 co-purifi-
cation was assayed by immunoblot. While the amounts
of GST-hDlg affinity-purified in untreated and PMA-
treated samples were comparable, hMEK2 co-purified
with hDlg only in PMA-treated samples (Figure 3A).
Both treated and untreated lysates expressed hMEK2 at
similar levels although hMEK2 phosphorylation level
was significantly increased by PMA treatment (Figure
3B). Our data shows that MEK2 is not pulled down
non-specifically by glutathione beads and suggest that in
this cellular context hDlg interacts very selectively with
the activated form of MEK2, which is present only in
PMA-treated cells. Nevertheless, we cannot rule out that
the activation of the Raf/MEK/ERK pathway resulted in
the phosphorylation of other proteins, including hDlg,
and that this may also contribute to the observed
interaction.
hDlg localizes to the midbody ring during cytokinesis
Because activated MEK2 is reported to localize to spin-
dle poles [27-29], kinetochores [29,30] and to the central
portion of the midbody in mitotic cells [31], we next
examined the localization of hDlg during various stages
of mitosis. MCF10A human breast carcinoma cells were
stained with affinity purified anti-hDlg (anti-NAG) and
anti-b-tubulin antibodies. The mitotic cells were staged
based on the appearance of their spindle in the b-tubu-
lin staining and that of their chromosomes stained by
DAPI, as well as from phase-contrast imaging of the cel-
lular membrane. From prophase to anaphase, hDlg was
distributed at the surface of condensed chromosomes
( F i g u r e4 A - C )a n da tt h ec e l lp e r i p h e r y( F i g u r e4 C ,
arrows). I2-containing hDlgv a r i a n t sw e r ep r e v i o u s l y
observed in the interphase nuclei of a variety of cells
types including MCF10A cells ([18] and AV, unpub-
lished data). During mitosis, it appears that the nuclear
variants of hDlg were not dispersed in the cytoplasm
but, instead, remained associated with condensed chro-
mosomes, distributed in discrete spots along their entire
length (Figure 4A-C). A set of contiguous Z-sections
was used to create a three-dimensional rendering of the
cell shown in Figure 4C. A 360° rotation of this render-
ing showed that there was no polarity in the distribution
of hDlg at the surface of metaphase chromosomes; it
was also present at the sides of the two sets of anaphase
chromosome facing each other (Figure 4C). Based on
this staining distribution, we conclude that hDlg was
not specifically associated with telomeric or kinetochore
proteins in mitotic cells, but spread all over the
chromosomes.
In cells in cytokinesis, midbody structures were easily
detected by immunostaining with anti-b-tubulin (Figure
4D). Co-staining with anti-NAG showed that hDlg was
located in the central portion of the midbody called the
midbody ring, and was not distributed along the bundles
of microtubules linking the two nascent daughter cells
(Figure 4E). Our data confirms similar observations of
hDlg at the midbody in HaCat skin keratinocytes, Saos2
and U2OS osteosarcoma cell lines by Massimi et al.
(2003; [23]) and in U2OS and HeLa cervical carcinoma
cells by Unno et al. (2008, [24]) although we found that
the localization of hDlg is restricted to the midbody
ring. A few proteins, such as b-tubulin, centriolin and
activated MEK2, are known to associate specifically with
the midbody ring while others, such as Aurora B, are
hMEK2   GWLCKTLRLNQPGTPTRTA-V
mMEK2   GWLCRTLRLKQPSTPTRTA-V
rMEK2   GWLCRTLRLKQPSTPTRTA-V
chMEK2  GWLCKTLRLNQPSTPTRAA-V
hMEK1   GWLCSTIGLNQPSTPTHAAGV
mMEK1   GWLCSTIGLNQPSTPTHAASI
rMEK1   GWLCSTIGLNQPSTPTHAASI
rbMEK1  GWLCSTIGLNQPSTPTHAAGV
Figure 1 Alignment of the C-terminal sequences of MEK1 and
MEK2. The last three residues of MEK2 proteins (with the exception
of MEK2 from chicken) suggest that MEK2 is characterized by a
Class I PDZ-binding motif. This motif is absent in MEK1 proteins. A
set of three conserved basic residues (highlighted in black) is also a
feature specific of MEK2 proteins. The sources for the aligned
sequences are: human MEK2 (hMEK2, NP_109587), mouse MEK2
(mMEK2, AAH14830), rat MEK2 (rMEK2, 2113192A), chicken MEK2
(chMEK2, NP_990719), human MEK1 (hMEK1, NP_002746), mouse
MEK1 (mMEK1, NP_032953), rat MEK1 (rMEK1, NP_113831), and
rabbit MEK1 (rbMEK1, P29678).
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unpublished data). This co-localization of activated
MEK2 and hDlg to the very limited structure of the
midbody ring suggests that hDlg could recruit or anchor
activated MEK2 in a particular signaling complex at the
midbody.
To verify that the distribution of hDlg that we
o b s e r v e dd i dn o ts i m p l yr e f l e c ta nu n r e g u l a t e do rn o n -
specific interaction with tubulin subunits or microtu-
bule-associated proteins, we looked more closely at the
co-staining of midbody structures with anti-hDlg and
anti-b-tubulin antibodies in cells at late stages of cell
division. The distribution of hDlg during late anaphase
or early cytokinesis showed that it localizes near micro-
tubules plus ends (Figure 4G-J). Before constriction of
the cytoplasmic bridge, hDlg was distributed in a narrow
line enriched in tubulin in the middle of the central
spindle (Figure 4G-I). A cross-section of the midbody
ring structure reconstituted from contiguous Z-sections
showed that, before membrane constriction, hDlg was
concentrated at the center of the ring structure rather
than distributed at its periphery (Figure 4J). The overlap
1754.73
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Figure 2 The C-terminal sequence of MEK2 binds to the PDZ repeats of hDlg. Peptides corresponding to the C-terminal end of human
MEK2 (2CT) or human MEK1 (1CT), and a randomized version of 2CT (2RD) were assayed for binding to a polypeptide comprising PDZ1-PDZ2 of
hDlg fused to GST (PDZ1-2). Bound fractions were analyzed by SELDI on H4 spots on a ProteinChip array (see material and methods). The area
under the peak (arbitrary units) was proportional to the amount of bound peptide. (A) While 2CT bound to GST-PDZ1-2, no detectable peptide
peak was observed when either 1CT or 2RD were tested for binding to GST-PDZ1-2; an assay with an unrelated GST fusion protein (a14)
established the binding specificity of 2CT. (B) 2CT also bound to individual PDZ repeats fused with GST (PDZ1, left and PDZ2, middle). In this
assay, the analysis of 2CT directly spotted on the ProteinChip array showed that protein-bound 2CT and free 2CT occupied the same position on
MALDI spectra (right). Preliminary experiments showed that both 1CT and 2RD can be detected by SELDI (data not shown).
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Page 4 of 12between tubulin and hDlg staining was only partial and
in most cases hDlg appeared juxtaposed to microtubules
(Figure 4J), clearly showing that the association of hDlg
with the midbody ring is not simply due to an unregu-
lated association with tubulin.
Finally, when staining with an antibody that specifi-
cally recognizes the membrane-associated hDlg variants
(containing the I3 alternatively spliced insert [18]) we
found that they localized to the midbody ring (Figure
4G-J). Strikingly, staining with affinity purified antibo-
dies raised against the alternatively spliced insertion I2,
present in nuclear variants of hDlg, failed to label this
structure (data not shown). Therefore we conclude that
only the membrane-bound form of hDlg was recruited
to the midbody, where it is found specifically at the
midbody ring, near microtubule plus ends. In contrast,
the I2-containing variants remains associated with the
chromosomes. This isoform-specific localization of
endogenously expressed hDlg contrasts with the non-
specific localization of both I3- and I2-containing iso-
forms others have found for overexpressed full-length or
truncated C-terminal forms of hDlg [23,24].
E-cadherin is necessary for localization of hDlg but not
phosphorylated MEK2 to the midbody ring during
cytokinesis
We have previously reported that hDlg is closely asso-
ciated with E-cadherin adhesion complexes in epithelial
cells [21]. Interestingly, staining for both E-cadherin and
hDlg in subconfluent growing Caco-2/15 colorectal
epithelial cells showed that both proteins co-localized at
the midbody ring during cytokinesis (Figure 5A). To
investigate whether E-cadherin controls the localization
of hDlg and phosphorylated MEK2 to the midbody, E-
cadherin expression was knocked down with RNA inter-
ference (Figure 5B-C). Reduction in E-cadherin levels
markedly attenuated hDlg staining to the midbody (Fig-
ure 5B, F). With both E-cadherin and hDlg missing
from the midbody, it appeared as if its structure was
altered, as we consistently observed that the width of b-
tubulin staining was reduced along the central spindle
(Figure 5E). Although the midbody size in both control
cells (no RNAi treatment and shGFP-transfected) and E-
cadherin knockdown cells was variable, we found that
on average, there was a clear, and highly statistically sig-
nificant difference in the average midbody width (two-
tailed Student’t t-test, p = 0.002 for shE-cadherin vs.
shGFP, p = 0.007 for shE-cadherin vs. no RNAi; Figure
5D). Somewhat surprisingly however, midbody staining
for phosphorylated MEK2 was not affected by E-cad-
herin downregulation (Figure 5F). From these results we
conclude that while E-cadherin is necessary for the loca-
lization of the I3-containing isoform of hDlg to the mid-
body ring during cytokinesis, the presence of neither of
these proteins at the midbody structure is necessary for
the recruitment of phosphorylated MEK2.
Discussion
Although hDlg is known to localize to sites of cell-cell
contacts, to interphase nuclei, and to the midbody of
cells in cytokinesis [2,18,23], little is known about its
binding partners at sites other than cell-cell contacts.
Here we report that hDlg associates with activated
MEK2, a protein specifically found at the midbody ring
during cytokinesis [31]. Using in vitro binding assays, we
found that the PDZ domains of hDlg interact directly
with the C-terminal peptide of MEK2, which contains a
Class I consensus PDZ-binding motif. Interestingly,
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Figure 3 hDlg interacts with activated MEK2. A GST-hDlg fusion
protein and MEK2 were co-expressed in insect cells. Lysates from
PMA-treated (+) and untreated (-) cells were incubated with GSH-
agarose and the content of the bound fractions was submitted to
SDS-PAGE and transferred onto nitrocellulose. The membrane was
probed with anti-hDlg (a-NAG) and anti-MEK2 (a-MEK2) antibodies.
The membrane was scanned with a dual laser Odyssey system to
co-detect hDlg (left panel, A) and MEK2 (middle panel, A). The right
panel in A shows the overlay of the two scans. Full-length hDlg and
full-length MEK2 are identified by arrow heads. The multiple bands
detected by anti-hDlg antibodies correspond to breakdown
products consistently observed when hDlg is overexpressed in
insect cells. Panel B shows immunoblots of lysates from PMA-
treated (+) and untreated (-) cells that were infected with
baculovirus for the expression of MEK2 alone or in combination
with baculovirus driving the expression of hDlg and probed with
anti-MEK2 (a-MEK2, left) and anti-phospho-MEK1/2 (a-phospho-
MEK2, right).
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Page 5 of 12while others have very recently shown partial co-precipi-
tation of hDlg and MEK2 from asynchronous HEK-293
and human vascular endothelial cell lysates [33], in the
cellular contexts we tested, the association between
hDlg and full-length MEK2 is only detectable when
MEK2 is activated. Several lines of evidence, including
these data, suggest that the C-terminal PDZ-binding
motif of full-length MEK2 may only be accessible to
hDlg in the activated protein. Structural studies have
shown that upon activation, MEK2 likely undergoes a
change of conformation common to other kinases
[34,35]. This change of conformation results in the rela-
tive rotation of the N- and C-terminal lobed-structures
forming the catalytic domain. It is unknown how this
rotation affects the C-terminal PDZ-binding sequence of
MEK2 because the C-terminal seven amino acids,
including this region, were not well ordered in the
MEK2 structure [35]. Nevertheless, the crystallographic
structure of MEK2 bound to Mg-ATP and a small mole-
cule non-competitive inhibitor, PD334581, clearly shows
that in this active-conformation homodimer, the PDZ-
binding sequences should be accessible to the PDZ
DAPI DAPI DAPI
DAPI DAPI DAPI
DAPI DAPI DAPI
ĮIKDOJ ĮIKDOJ
ĮIKDOJ
ĮȕWXEXOLQ
ĮȕWXEXOLQ
ĮȕWXEXOLQ
ĮȕWXEXOLQ
Į1A* Į1A*
Į1A*Į  1 A*Į  1 A*
Figure 4 Distribution of hDlg during mitosis. MCF10A cells at different stages of mitosis were stained with antibodies directed against total
hDlg (all variants, a-NAG, Panels A-F) or antibodies raised against the alternatively spliced insert I3 (Panels G-J); both antibodies have previously
been extensively validated for specificity against hDlg [18,44]. Cells were co-stained with antibodies directed against b-tubulin (Panels D and G).
The image overlays in panels F, I, and J show the relative distribution of hDlg (green) and microtubules (red). These images were produced by
deconvolution of contiguous Z-sections. Panel J shows a reconstruction of a cross-section of the midbody ring structure co-stained with anti-I3
(green) and anti-b tubulin (red) antibodies. This cross-section is orthogonal to the central spindle. DNA (blue) was visualized by DAPI staining.
The white arrows (Panel C) indicate the position of the cell membrane. All scale bars are 10 μm.
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Figure 5 Impact of E-cadherin downregulation on localization of hDlg and activated MEK2 at the midbody. Subconfluent Caco-2/15 cells
were stained with antibodies directed against total hDlg (a-NAG, red) or against E-cadherin (green) (Panel A). Caco-2/15 cells stably infected
with lentiviruses encoding for a control shRNA (shGFP) or encoding an E-cadherin-specific shRNA were lysed and proteins were analyzed by
Western blotting for expression of E-cadherin and b-actin (Panel C). Caco-2/15 cells stably expressing shGFP or shE-cadherin were stained with
antibodies directed against E-cadherin (red) and b-tubulin (green) (Panel B), against b-tubulin alone (green) (Panel E) or against hDlg (Santa Cruz
antibody, red) and phospho-MEK (green) (Panel F). In all images, DNA (blue) was visualized by DAPI staining and scale bars are 10 μm. Midbody
widths were determined at their central portion for cells that were not infected (no RNAi), or stably expressing lentiviral-coded control (shGFP)
or E-cadherin specific shRNAs (Panel D). Error bars represent the standard deviation across the population of cells (number of cells for each
sample is indicated on the graph); asterisks indicate that the average for E-cadherin shRNA-expressing cells is statistically different from that of
both control cell populations (two-tailed Student t-test) at p ≤ 0.01.
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Page 7 of 12repeats of hDlg. Although not structured, the C-terminal
seven residues would extend at the periphery of the
complex, near the ATP binding site, and not be buried
in the dimer interface [35]. Further supporting our
hypothesis, we note that both the MEK2 clone isolated
in our two-hybrid screen and the clone identified in a
similar screen by Magai et al. (2011, [33]) coded for
only the C-terminal portion of MEK2. Therefore in
assays using a C-terminal fragment of MEK2 (Ref. [33]
and herein), or a C-terminal MEK2 peptide (herein), the
C-terminal PDZ-binding motif is likely more exposed
than in full-length MEK2 clones, allowing for an inter-
action that is normally regulated by a phosphorylation-
driven conformational change in the full-length protein.
While our results and those of Maiga et al. [33] provide
some initial information as to the binding specificities
and the mode of interaction between hDlg and MEK2, a
better understanding of how, and in which context,
these two proteins can interact will require further
structural studies. Other unresolved questions include
how the intramolecular interaction between the GK and
SH3 domains of hDlg, the self-association of hDlg pro-
teins via their N-terminal ends, and the identity of hDlg
splice variants contribute to the regulation of its binding
to MEK2.
The role of MEK/ERK-dependent signaling in the con-
trol of cell-cycle has been extensively studied, particu-
larly its role in G1/S phase transition. Recent studies
have shown that activation of this signaling pathway is
also required for mitotic progression. During late ana-
phase and cytokinesis, the two nascent daughter cells
are separated by a cytoplasmic bridge characterized by a
bundle of antiparallel microtubules forming the central
spindle. At the half-point of the central spindle, a struc-
ture called the midbody determines the site of cell
abscission and recruits proteins that are necessary for
the completion of mitosis. The activated forms of
MEK1/2, ERK and the ERK substrates RSK1-3 are found
in the central spindle and in the midbody [29-31]. Inhi-
bition of MEK activity prevents the completion of mito-
sis in cells released from nocodazole-mediated mitotic
arrest, thus suggesting the role of MEK1/2 and down-
stream substrates in cytokinesis [31,36]. The interaction
observed between hDlg and activated MEK2 suggests
that both proteins should co-distribute at specific stages
of the cell cycle when MEK2 is activated. Indeed, we
have found that certain variants of hDlg, like activated
MEK2, localize specifically to the midbody ring structure
during cytokinesis.
It is unclear how hDlg is targeted to the midbody,
however, because the PDZ domains of hDlg are insuffi-
cient to target the protein to the midbody [23], it cannot
rely on activated MEK2. Others have shown that a pro-
tein fragment spanning only the C-terminal SH3 and
GK domains of hDlg localized to the midbody when
overexpressed, competing with endogenous hDlg and
disrupting cell growth [23]. The GK domain of hDlg
alone localizes to the midbody and causes a mild cyto-
kinesis defect when overexpressed [24]. This suggests
that while the N-terminal region of hDlg, including its
PDZ domains, may be dispensable for proper localiza-
tion of hDlg at the midbody, it is essential to its
function.
A possibility raised by our data is that membrane-
bound I3-variants of hDlg are redistributed to the mid-
body. I3-variants of hDlg were previously found to be
localized to the membrane at sites of cell-cell junctions
[19]. Membrane-bound hDlg was demonstrated to be
closely associated with E-cadherin-containing adhesion
complexes in human epithelial cells and cells deficient
in hDlg expression fail to organize their cortical actin
cytoskeleton and are unable to stabilize their adherens
junctions [21]. E-cadherin protein was also previously
found in the cleavage furrow of mitotic epithelial cells,
consistent with the observation that the daughter cells
form adherens junctions with each other immediately
following cytokinesis and are not separated by neighbor-
ing cells [37]. Herein, we demonstrate that E-cadherin
expression is required for localization of hDlg to the
midbody in the same epithelial cells. E-cadherin deple-
tion also led to a marked narrowing of the midbody
structure. While our data does not specifically address
whether E-cadherin depletion itself or its effect on the
central spindle are the direct cause of the mis-localiza-
tion of hDlg, because E-cadherin and hDlg are known to
physically interact in confluent epithelial cells [21], we
surmise that E-cadherin may directly recruit hDlg to the
midbody. Taken together, these data suggest that hDlg
may also be important for the formation of adherens
junction between the two daughter cells.
Membrane-bound I3-containing variants of hDlg
could either relocalize to the midbody from existing
adherens junction sites or be recruited to the midbody
from intracellular membrane systems. In this report, we
show that the localization of hDlg to the midbody ring
precedes the constriction of the intracellular cytoplasmic
bridge, while post-Golgi secretory vesicles are delivered
to the site of abscission after membrane constriction,
during the late stage of cytokinesis [32], arguing against
recruitment from intracellular membranes. Although
only I3-variants of hDlg are preferentially associated
with membrane systems [18,19], others have shown that
the transport and/or anchoring of overexpressed hDlg
to the midbody is independent of I2 and I3 [23,24].
Taken together our findings and those from these pre-
vious reports are consistent with the idea that SH3- or
GK-binding proteins are responsible for the transport
and or anchoring of hDlg to the midbody, while
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mine which pool of hDlg relocalizes to this site, perhaps
by regulating the accessibility of the GK domain.
hDlg plays an important role in clustering signaling
molecules at different intracellular sites. In this report,
we describe the interaction of hDlg with MEK2 which
was also reported recently by Maiga et al. [33]. In con-
trast to hDlg, however, the recruitment of phosphory-
lated MEK2 to the midbody seems to occur normally in
E-cadherin-depleted cells indicating that although other
assays show that hDlg can bind directly to phosphory-
lated MEK2, hDlg is not required for MEK2 recruitment
to the midbody. Nevertheless, we cannot exclude that
hDlg may serve as a scaffold to form a signalosome that
is responsive to MEK/ERK signaling during cytokinesis.
Previous studies have identified several other kinases
that bind to hDlg. First, PBK/TOPK, a kinase which is
activated during mitosis by the cyclin B/CDK1 complex
and then phosphorylates p38-MAPK, interacts with the
PDZ repeats of hDlg [9,38]. Interestingly, an activated
form of PBK/TOPK was recently found to be associated
with the central spindle and to promote cytokinesis [39];
this association with the central spindle may reflect its
interaction with hDlg. A second kinase interacting with
hDlg is p85/PI3K, which it recruits to E-cadherin-
mediated sites of cell-cell contact in human intestinal
epithelial cells where hDlg plays a key role in the orga-
nization and stabilization of adherens junctions [21].
Importantly, this recruitment of p85/PI3K is dependent
on a change in the phosphorylation pattern of hDlg trig-
g e r e db yay e tu n i d e n t i f i e dk i n a s e[ 2 1 ] .F i n a l l y ,t h e
SAPK3/p38g MAPK is also known to interact with the
PDZ repeats of hDlg and to phosphorylate hDlg. Phos-
phorylation of hDlg by SAPK3/p38g MAPK results in its
dissociation from the cytoskeleton, apparently by dis-
rupting the interaction between the GK domain of hDlg
and its binding partner GKAP [10]. Therefore, not only
is hDlg implicated in the recruitement of several kinases
at specialized sites in cells but, in turn, the activity of
hDlg, and potentially its localization, is modulated by
kinases.
Conclusions
In summary, we show that specific variants of hDlg
associate with the midbody ring structure during late
anaphase and cytokinesis and that the midbody localiza-
tion of hDlg is dependent on the expression of E-cad-
herin. A clear understanding of the functions that hDlg
performs at different intracellular sites requires the iden-
tification of all its interaction partners. We demonstrate
that hDlg directly interacts with a component of the
MAP kinase pathway, MEK2, specifically in cells where
MEK2 is activated. Activated MEK2 is known to also
localize to the midbody ring structure during late
mitosis. Future studies will reveal how hDlg and MEK2
work together to regulate cell cycle events and cellular
proliferation.
Methods
Two-hybrid screen
A two-hybrid screen was performed using the Match-
Maker system (Invitrogen). A clone of S. cerevisiae
HF7c transformed with the pGBT9-hDlg construct
(HF7c/hDlg) was selected based on its expression of
hDlg as detected by immunoblot. HF7c/hDlg cells were
then transformed with 250 μgo ft h ep G A D - G HH e L a
cDNA library (Invitrogen) using lithium-acetate. The
transformants were plated on SD (Leu
-,T r p
- and His
-)
medium supplemented with 5 mM 3-amino triazole and
incubated 7 days at 30°C. Of approximately 750,000
transformants, 2010 were HIS3
+ and of these, 236 were
reproducibly positive for b-galactosidase activity. The
transformants with the strongest b-galactosidase activity
were further validated and tested for false positives by
isolating plasmid DNA and transforming single clonal
plasmid DNA in HF7c or co-transforming with pGBT9,
pLAM5’ and finally with pGBT9-hDlg.
Cell culture and reagents
Sf9 and High 5 insect cells (Invitrogen) were grown in
Grace’s media supplemented with 10% fetal bovine
serum and in BaculoGold protein-free insect cell med-
ium respectively (Invitrogen). MCF10A human immor-
talized mammary epithelial cells (ATCC, Manassas, VA)
were grown in Ham’s DMEM/F12 supplemented with
0.1 μg/ml cholera toxin, 12 μg/ml insulin, 0.5 μg/ml
hydrocortisone, 0.02 μg/ml epidermal growth factor, and
5% chelexed horse serum (Invitrogen) under a 5% CO2
atmosphere at 37°C. The Caco-2/15 human colon ade-
nocarcinoma cells were obtained from Dr A. Quaroni
(Cornell University, Ithaca, NY) and cultured in DMEM
containing 10% FCS, as described previously [40].
Protein co-expression in insect cells
A cDNA coding for a full-length variant of hDlg lacking
alternatively spliced insertions I1A and I1B but contain-
ing insertions I3 and I5 [18] was subcloned into the
baculovirus transfer vector pAcGHLT-B (Pharmingen).
Recombinant baculoviruses were produced by the co-
transfection of Sf9 cells with pAcGHLT-B/hDlg and
BaculoGold DNA (Pharmingen).
Human MEK2 cloned into pCMV (kindly provided by
Dr. Kun-Liang Guan, University of Michigan, Ann
A r b o r )w a su s e da st e m p l a t et op r o d u c e daP C Rp r o -
duct coding for full-length MEK2. This PCR product
was subcloned into the pBlueBak4.5/V5-His-TOPO
baculovirus transfer vector (Invitrogen). Recombinant
baculoviruses were produced by the co-transfection of
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DNA (Invitrogen).
High 5 insect cells were infected at high multiplicity of
infection with hDlg and MEK2 recombinant baculovirus
alone or in combination. Infected cells were harvested
after three days and cell pellets were stored at -80°C
until further processing. In some cases, infected High 5
cells were stimulated with 1 μM phorbol 12-myristate
13-acetate (PMA) for 1 h at 27°C before harvesting.
Protein purification
cDNAs coding for hDlg PDZ repeats 1 and 2 or a-spec-
trin repeat 14 were cloned into a modified version of
the expression vector pGEX (Pharmacia) and GST
fusion proteins GST-PDZ1-2 and GST-a14 were
expressed and purified as described previously [19,41].
To isolate GST-hDlg and its associated proteins, pel-
lets of infected High 5 cells were resuspended in 1 to
1.5 ml of insect cell lysis buffer supplemented with a
cocktail of protease inhibitor (Pharmingen) and phos-
phatase inhibitors (sodium orthovanadate and sodium
fluoride). Samples were placed on ice for 30 min and
then homogenized in a tissue grinder. The lysate was
clarified by centrifugation at 14,000 rpm for 30 min, and
then incubated with GSH-agarose beads (Sigma-Aldrich)
for 1 h at 4°C. The GSH-beads were then washed three
times with PBS supplemented with 0.01% Tween 20 and
phosphatase inhibitors. The isolated proteins were
eluted from the beads with SDS-PAGE sample buffer.
Peptide binding assays
Peptides corresponding to the C-terminal portion of
MEK2 (2CT: KTLRLNQPGTPTRTAV), MEK1 (1CT:
TIGLNQPSTPTHAAGV), and a randomized version of
t h e2 C Tp e p t i d es e q u e n c e( 2 R D :R K T L G N R P P L V
TTAQT) were synthesized by the peptide synthesis core
facility (Massachusetts General Hospital CNY). Purity
and quality of the synthesized peptides was confirmed
by reverse-phase chromatography and MALDI-TOF.
40 μgo fG S T - P D Z 1 - 2o r9 0μgo fG S T - a14 fusion
proteins bound to 20 μl GSH-agarose beads were incu-
bated with 8 μg of peptides for 2 h at 4°C. The beads
were then washed twice with PBS-0.01% Triton X-100,
and three times with 50 mM Tris, pH 7.6. Bound pep-
tides were then eluted from the agarose beads by two
sequential 5 min incubations, each with one bead-
volume of 30% acetic acid.
To analyze the eluted peptides, spots on H4 Pro-
teinChip arrays (Ciphergen) were pretreated with 50%
acetonitrile, and then 4 μl of an eluted fraction was
applied to each spot and allowed to dry. Next, 0.5 μlo f
a saturated solution of the energy absorbing a-cyano-4-
hydroxycinnamic acid (CHCA, Sigma-Aldrich) diluted
1:5 in 50% acetonitrile and 0.5% trifluoroacetic acid was
applied to each spot. Adsorbed peptides were detected
using the ProteinChip Biology system reader IIC
(Ciphergen).
Immunoblots
To analyze the lysates of cells infected with baculo-
viruses coding for the expression of MEK2 (with or
without hDlg co-expression, and with or without PMA
treatment) as well as the proteins complexes co-purified
with GST-hDlg from High 5 insect cells, the lysates or
proteins affinity purified with GSH-agarose beads were
resolved by reducing and denaturing electrophoresis on
a 10-20% tricine gel, and then transferred onto nitrocel-
lulose membranes. The membranes were blocked for 2
h at room temperature with Odyssey blocking buffer
(Li-Cor Biosciences) and probed overnight at 4°C with
mouse anti-MEK2 (Santa Cruz Biotechnology Inc) and
rabbit anti-hDlg (anti-NAG, [18]) or rabbit anti-phos-
pho-MEK1/2 (Cell Signaling Technology) primary anti-
bodies. After washing, the membranes were incubated
w i t hA l e x a6 8 0 - c o n j u g a t e dg o a ta n t i - r a b b i t( M o l e c u l a r
probes) and IRDye 800-conjugated goat anti-mouse
(Rockland immunochemicals, Inc.) secondary antibodies.
Membranes were analyzed with the Odyssey Imaging
system (Li-Cor Biosciences).
To measure E-cadherin expression levels in Caco-2/15
cells, the cells were lysed in SDS-sample buffer (62.5
mM Tris-HCl [pH 6.8], 2.3% SDS, 10% glycerol, 5% b-
mercaptoethanol, 0.005% bromophenol blue, 1 mM
PMSF). Protein concentrations were measured using a
modified Lowry procedure with BSA as standard [42].
Equal amounts of proteins from whole cell lysates were
separated by SDS-PAGE in 10% gels and electrotrans-
ferred onto PVDF membranes (PerkinElmer). Mem-
branes were blocked for 1 h at 25°C in PBS containing
5% powdered milk and 0.05% Tween-20 and then incu-
bated overnight at 4°C with mouse anti-E-cadherin (BD
Biosciences) or mouse anti-actin (Chemicon) primary
antibodies followed by incubation with horseradish per-
oxidase-conjugated goat anti-mouse IgG (GE Health-
care) for 1 h at 25°C. The blots were visualized by the
Amersham ECL system.
Immunostainings
MCF10A cells grown on glass coverslips were washed
w i t hP B Sa n df i x e da tl e a s t1hi nc o l dm e t h a n o l .F i x e d
cells were rehydrated in PBS, and then incubated in pri-
mary antibodies in PBS with 3% BSA for 1 h at 37°C.
After washing three times in PBS, the cells were incu-
bated with the secondary antibodies in PBS with 3%
BSA for 30 min at 37°C. The cells were washed once in
PBS, stained 5 min at room temperature with 1 μg/ml
DAPI in PBS and then washed twice in PBS before
mounting in Prolong anti-bleaching agent (Invitrogen).
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anti-I3 [18], and anti-b-tubulin (Santa Cruz Biotechnol-
ogy Inc.) as primary antibodies and Cy5-conjugated goat
anti-mouse (Zymed) or FITC-conjugated donkey anti-
rabbit (Zymed) as secondary antibodies. Images were
captured using an Applied Precision deconvolution
microscope. The Z-series were deconvolved using Soft-
WoRx (Applied Precision Inc., Seattle, WA) and shown
as maximum intensity quick projections.
Subconfluent Caco-2/15 cells grown on glass cover-
slips were washed twice with ice-cold PBS and fixed in
paraformaldehyde (3%) for 20 min at room temperature.
Fixed cells were then permeabilized with 0.1% Triton X-
100 in PBS for 10 min and blocked with PBS-BSA 2%
(30 min at 25°C). Cells were then incubated 2 h at 25°C
with mouse anti-E-cadherin (Chemicon), rabbit or
mouse anti-hDlg (a-NAG and mouse anti-Dlg1 from
Santa Cruz Biotechnologies, respectively), goat anti-b-
tubulin (Abcam) or rabbit anti-phospho-MEK (Cell Sig-
naling Technology) followed by 30 min at 25°C with
Alexa 488 and Alexa 568-conjugated secondary antibo-
dies (Invitrogen). The cells were finally stained 5 min at
25°C with 1 μg/ml DAPI in PBS. Negative controls (no
primary antibody) were included in all experiments.
Images were captured using a Leica DM STC micro-
s c o p eu s i n ge i t h e ra2 0 Xo ra4 0 Xo b j e c t i v e( L e i c a
Instruments). Magnification was calibrated by compari-
son with a stage micrometer (Graticules™ Ltd., Ton-
bridge, UK). Midbody widths at their central portion
were determined using the MetaMorph program (Uni-
versal Imaging Corporation, Sunnyvale, CA, USA). Sta-
tistics were calculated using the Student’st w o - t a i l e dt
test.
RNA interference
The shRNA against E-cadherin (TRCN0000039666) and
the control shRNA against TurboGFP
TM (SHC004) were
obtained from Sigma-Aldrich. All lentiviruses were pro-
duced and used for cell infection according to Invitro-
gen recommendations (ViraPower Lentiviral Expression
System, instructions manual). In each experiment with
lentiviruses, OAS1 gene expression was analyzed by Q-
PCR analysis. OAS1 (2’5’-oligoadenylate synthetase) is a
classic interferon target gene and it has been recom-
mended as a key test for interferon induction before
attributing a particular response to the gene targeted
[43]. No induction of OAS1 expression was detected in
the experiments involving lentiviruses infection (data
not shown).
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